Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Small, EJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 69 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Harris, KA; Small, EJ
      Hormonal treatment for prostate cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Small, EJ; Harris, KA; Frohlich, MW; Bok, R
      The UCSF advanced prostate cancer program

      UROLOGIC ONCOLOGY
    3. George, DJ; Halabi, S; Shepard, TF; Vogelzang, NJ; Hayes, DF; Small, EJ; Kantoff, PW
      Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on cancer andleukemia group B 9480

      CLINICAL CANCER RESEARCH
    4. Ko, YJ; Small, EJ; Kabbinavar, F; Chachoua, A; Taneja, S; Reese, D; DePaoli, A; Hannah, A; Balk, SP; Bubley, GJ
      A multi-institutional Phase II study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer

      CLINICAL CANCER RESEARCH
    5. Mehta, R; Kyshtoobayeva, A; Kurosaki, T; Small, EJ; Kim, H; Stroup, R; McLaren, CE; Li, KT; Fruehauf, JP
      Independent association of angiogenesis index with outcome in prostate cancer

      CLINICAL CANCER RESEARCH
    6. Rini, BI; Small, EJ
      An update on prostate cancer

      CURRENT OPINION IN ONCOLOGY
    7. Small, EJ
      Docetaxel in prostate cancer

      ANTI-CANCER DRUGS
    8. Savarese, DM; Halabi, S; Hars, V; Akerley, WL; Taplin, ME; Godley, PA; Hussain, A; Small, EJ; Vogelzang, NJ
      Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780

      JOURNAL OF CLINICAL ONCOLOGY
    9. Small, EJ; McMillan, A; Meyer, M; Chen, L; Slichenmyer, WJ; Lenehan, PF; Eisenberger, M
      Serum prostate-specific antigen decline as a marker of clinical outcome inhormone-refractory prostate cancer patients: Association with progression-free survival, pain end points, and survival

      JOURNAL OF CLINICAL ONCOLOGY
    10. Kantoff, PW; Halabi, S; Farmer, DA; Hayes, DF; Vogelzang, NA; Small, EJ
      Prognostic significance of reverse transcriptase polymerase chain reactionfor prostate-specific antigen in men with hormone-refractory prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    11. Kelly, WK; Curley, T; Slovin, S; Heller, G; McCaffrey, J; Bajorin, D; Ciolino, A; Regan, K; Schwartz, M; Kantoff, P; George, D; Oh, W; Smith, M; Kaufman, D; Small, EJ; Schwartz, L; Larson, S; Tong, W; Scher, H
      Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Small, EJ; Bok, R; Reese, DM; Sudilovsky, D; Frohlich, M
      Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer

      SEMINARS IN ONCOLOGY
    13. Grossfeld, GD; Small, EJ; Lubeck, DP; Latini, D; Broering, JM; Carroll, PR
      Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

      UROLOGY
    14. Grossfeld, GD; Chaudhary, UB; Reese, DM; Carroll, PR; Small, EJ
      Intermittent androgen deprivation: Update of cycling characteristics in patients without clinically apparent metastatic prostate cancer

      UROLOGY
    15. Bok, RA; Halabi, S; Fei, DT; Rodriquez, CR; Hayes, DF; Vogelzang, NJ; Kantoff, P; Shuman, MA; Small, EJ
      Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: A cancer and leukemia group B study

      CANCER RESEARCH
    16. Reese, DM; Small, EJ; Magrane, G; Waldman, FM; Chew, K; Sudilovsky, D
      HER2 protein expression and gene amplification in androgen-independent prostate cancer

      AJCP. American journal of clinical pathology
    17. Small, EJ; Reese, DM
      An update on prostate cancer research

      CURRENT OPINION IN ONCOLOGY
    18. Small, EJ
      Management of advanced/metastatic prostate cancer: 2000 update - The Hussain/Dawson article reviewed

      ONCOLOGY-NEW YORK
    19. Small, EJ; Meyer, M; Marshall, ME; Reyno, LM; Meyers, FJ; Natale, RB; Lenehan, PF; Chen, L; Slichenmyer, WJ; Eisenberger, M
      Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone

      JOURNAL OF CLINICAL ONCOLOGY
    20. Hussain, M; Fisher, EI; Petrylak, DP; O'Connor, J; Wood, DP; Small, EJ; Eisenberger, MA; Crawford, ED
      Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A southwest oncology group study

      JOURNAL OF CLINICAL ONCOLOGY
    21. Small, EJ; Fratesi, P; Reese, DM; Strang, G; Laus, R; Peshwa, MV; Valone, FH
      Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

      JOURNAL OF CLINICAL ONCOLOGY
    22. Small, EJ; Frohlich, MW; Bok, R; Shinohara, K; Grossfeld, G; Rozenblat, Z; Kelly, WK; Corry, M; Reese, DM
      Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    23. Roach, M; Reese, D; Weinberg, V; Small, EJ; Carroll, PR
      Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?

      JOURNAL OF CLINICAL ONCOLOGY
    24. Small, EJ; Lew, D; Redman, BG; Petrylak, DP; Hammond, N; Gross, HM; Eastham, JA; Crawford, ED
      Southwest oncology group study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: The importance of survival as a clinical trialend point

      JOURNAL OF CLINICAL ONCOLOGY
    25. Small, EJ; Figlin, R; Petrylak, D; Vaughn, DJ; Sartor, O; Horak, I; Pincus, R; Kremer, A; Bowden, C
      A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma

      INVESTIGATIONAL NEW DRUGS
    26. Tigrani, VS; Reese, DM; Small, EJ; Presti, JC; Carroll, PR
      Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: A retrospective analysis

      UROLOGY
    27. Small, EJ; Reese, DM
      New treatment strategies in advanced prostate cancer

      RADIOLOGIC CLINICS OF NORTH AMERICA
    28. Grossfeld, GD; Tigrani, VS; Nudell, D; Roach, M; Weinberg, VK; Presti, JC; Small, EJ; Carroll, PR
      Management of a positive surgical margin after radical prostatectomy: Decision analysis

      JOURNAL OF UROLOGY
    29. Grossfeld, GD; Tigrani, VS; Nudell, D; Roach, M; Weinberg, VK; Presti, JC; Small, EJ; Carroll, PR
      Management of a positive surgical margin after radical prostatectomy: Decision analysis - Reply

      JOURNAL OF UROLOGY
    30. Reese, DM; Corry, M; Small, EJ
      Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma

      CANCER
    31. Dawson, NA; Conaway, M; Halabi, S; Winer, EP; Small, EJ; Lake, D; Vogelzang, NJ
      A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma - Cancer and leukemia group B study 9181

      CANCER
    32. Small, EJ; Reese, DM; Um, B; Whisenant, S; Dixon, SC; Figg, WD
      Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor

      CLINICAL CANCER RESEARCH
    33. Bubley, GJ; Carducci, M; Dahut, W; Dawson, N; Daliani, D; Eisenberger, M; Figg, WD; Freidlin, B; Halabi, S; Hudes, G; Hussain, M; Kaplan, R; Myers, C; Oh, W; Petrylak, DP; Reed, E; Roth, B; Sartor, O; Scher, H; Simons, J; Sinibaldi, V; Small, EJ; Smith, MR; Trump, DL; Vollmer, R; Wilding, G
      Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group

      JOURNAL OF CLINICAL ONCOLOGY
    34. Bok, AB; Small, EJ
      The treatment of advanced prostate cancer with ketoconazole - Safety issues

      DRUG SAFETY
    35. Reese, DM; Small, EJ
      Secondary hormonal manipulations in hormone refractory prostate cancer

      UROLOGIC CLINICS OF NORTH AMERICA
    36. Small, EJ; Reese, DM; Vogelzang, NJ
      Hormone-refractory prostate cancer: An evolving standard of care

      SEMINARS IN ONCOLOGY
    37. Small, EJ
      PC-SPES in prostate cancer

      NEW ENGLAND JOURNAL OF MEDICINE
    38. Taplin, ME; Bubley, GJ; Ko, YJ; Small, EJ; Upton, M; Rajeshkumar, B; Balk, SP
      Selection for androgen receptor mutations in prostate cancers treated withandrogen antagonist

      CANCER RESEARCH
    39. Kashani-Sabet, M; Sagebiel, RW; Collins, HE; Glassberg, AB; Allen, RE; Leong, SPL; Small, EJ
      Outpatient combination chemoimmunotherapy for patients with metastatic melanoma - Results of a phase I/II trial

      CANCER
    40. Coakley, FV; Hricak, H; Presti, JC; Small, EJ
      Diffuse retroperitoneal amyloidosis due to renal cell carcinoma

      BRITISH JOURNAL OF RADIOLOGY
    41. SMALL EJ
      PROSTATE-CANCER - INCIDENCE, MANAGEMENT AND OUTCOMES

      Drugs & aging
    42. SMALL EJ; WEISS GR; MALIK UK; WALTHER PJ; JOHNSON D; WILDING G; KUZEL T; BEJAMONDE A; PATON V
      THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH RECOMBINANT HUMAN GAMMA-INTERFERON

      The cancer journal from Scientific American
    43. SMALL EJ; FIPPIN LJ; WHISENANT SP
      PYRAZOLOACRIDINE FOR THE TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER

      Cancer investigation
    44. FROHLICH MW; SMALL EJ
      STAGE-II NONSEMINOMATOUS TESTIS CANCER - THE ROLES OF PRIMARY AND ADJUVANT CHEMOTHERAPY

      Urologic clinics of North America
    45. GROSSFELD GD; SMALL EJ
      LONG-TERM SIDE-EFFECTS OF TREATMENT FOR TESTIS CANCER

      Urologic clinics of North America
    46. GROSSFELD GD; SMALL EJ; CARROLL PR
      INTERMITTENT ANDROGEN DEPRIVATION FOR CLINICALLY LOCALIZED PROSTATE-CANCER - INITIAL EXPERIENCE

      Urology
    47. SHADAN S; BHATT A; CHALLA S; PRICE D; SMALL EJ; HAWKINS RA
      THE UTILITY OF PROSTASCINT SCINTIGRAPHY FOR PROSTATE-CANCER METASTASIS OR RECURRENCE

      Radiology
    48. SMALL EJ; WHISENANT S; GUILD C; FIGG WD
      IMMUNOLOGICAL THERAPY OF PROSTATE-CANCER WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)

      The Journal of urology
    49. SMALL EJ; VOGELZANG NJ
      2ND-LINE HORMONAL-THERAPY FOR ADVANCED PROSTATE-CANCER - A SHIFTING PARADIGM

      Journal of clinical oncology
    50. SMALL EJ
      CHARACTERIZATION OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATIC-CARCINOMA WHOSE SERUM PROSTATE-SPECIFIC ANTIGEN DECREASED FOLLOWING FLUTAMIDE WITHDRAWAL

      The Journal of urology
    51. SCHELLHAMMER PF; VENNER P; HAAS GP; SMALL EJ; NIEH PT; SEABAUGH DR; PATTERSON AL; KLEIN E; WAJSMAN Z; FURR B; CHEN YS; KOLVENBAG GJCM
      PROSTATE-SPECIFIC ANTIGEN DECREASES AFTER WITHDRAWAL OF ANTIANDROGEN THERAPY WITH BICALUTAMIDE OR FLUTAMIDE IN PATIENTS RECEIVING COMBINED ANDROGEN BLOCKADE

      The Journal of urology
    52. SMALL EJ; BARON AD; FIPPIN L; APODACA D
      KETOCONAZOLE RETAINS ACTIVITY IN ADVANCED PROSTATE-CANCER PATIENTS WITH PROGRESSION DESPITE FLUTAMIDE WITHDRAWAL

      The Journal of urology
    53. SMALL EJ; BARON A; BOK R
      SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND TREATMENT WITH KETOCONAZOLE AND HYDROCORTISONE IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA

      Cancer
    54. SMALL EJ; SRINIVAS S; EGAN B; MCMILLAN A; REARDEN TP
      DOXORUBICIN AND DOSE-ESCALATED CYCLOPHOSPHAMIDE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR THE TREATMENT OF HORMONE-RESISTANT PROSTATE-CANCER

      Journal of clinical oncology
    55. SMALL EJ; DAWSON NA; KANTOFF PW; VOGELZANG NJ
      CANCER AND LEUKEMIA GROUP-B TRIALS FOR ADVANCED PROSTATE-CANCER

      Seminars in oncology
    56. ROACH M; MEEHAN S; KROLL S; WEIL M; RYU J; SMALL EJ; MARGOLIS LW; PRESTI J; CARROLL PC; PHILLIPS TL
      RADIOTHERAPY FOR HIGH-GRADE CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE

      The Journal of urology
    57. SMALL EJ
      PROSTATE-SPECIFIC ANTIGEN AFTER GONADAL ANDROGEN WITHDRAWAL AND DEFERRED FLUTAMIDE TREATMENT

      The Journal of urology
    58. CHER ML; BOVA GS; MOORE DH; SMALL EJ; CARROLL PR; PIN SS; EPSTEIN JI; ISAACS WB; JENSEN RH
      GENETIC ALTERATIONS IN UNTREATED METASTASES AND ANDROGEN-INDEPENDENT PROSTATE-CANCER DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION AND ALLELOTYPING

      Cancer research
    59. SMALL EJ; FIPPIN LJ; ERNEST ML; CARROLL PR
      A CARBOPLATIN-BASED REGIMEN FOR THE TREATMENT OF PATIENTS WITH ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM

      Cancer
    60. TIMMERMAN JM; NORTHFELT DW; SMALL EJ
      MALIGNANT GERM-CELL TUMORS IN MEN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - NATURAL-HISTORY AND RESULTS OF THERAPY

      Journal of clinical oncology
    61. SMALL EJ; SRINIVAS S
      THE ANTIANDROGEN WITHDRAWAL SYNDROME - EXPERIENCE IN A LARGE COHORT OF UNSELECTED PATIENTS WITH ADVANCED PROSTRATE CANCER

      Cancer
    62. SMALL EJ
      HORMONAL-THERAPY FOR METASTATIC PROSTATE-CANCER

      Western journal of medicine
    63. SMALL EJ; CARROLL PR
      SERUM PSA DECLINE AFTER CASODEX WITHDRAWAL - REPLY

      Urology
    64. SMALL EJ; CARROLL PR
      PROSTATE-SPECIFIC ANTIGEN DECLINE AFTER CASODEX WITHDRAWAL - EVIDENCEFOR AN ANTIANDROGEN WITHDRAWAL SYNDROME

      Urology
    65. WOLF JS; ARONSON FR; SMALL EJ; CARROLL PR
      NEPHRECTOMY FOR METASTATIC RENAL-CELL CARCINOMA - A COMPONENT OF SYSTEMIC TREATMENT REGIMENS

      Journal of surgical oncology
    66. SMALL EJ; FRYE JW; WILKINSON MJ; CARROLL PR; ERNEST ML; STAGG RJ
      A PHASE I II STUDY OF ALTERNATING CONSTANT RATE INFUSION FLOXURIDINE WITH CONSTANT RATE INFUSION VINBLASTINE FOR THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA/

      Cancer
    67. SMALL EJ
      PROSTATE-CANCER - WHO TO SCREEN, AND WHAT THE RESULTS MEAN

      Geriatrics
    68. SMALL EJ; VENOOK AP; DAMON LE
      GALLIUM-AVID THYMIC HYPERPLASIA IN AN ADULT AFTER CHEMOTHERAPY FOR HODGKINS-DISEASE

      Cancer
    69. WILKINSON MJ; FRYE JW; SMALL EJ; VENOOK AP; CARROLL PR; ERNEST ML; STAGG RJ
      A PHASE-II STUDY OF CONSTANT-INFUSION FLOXURIDINE FOR THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 18:22:30